Transcript Quantum Genomics 0 2006

Quantum Genomics in
France
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Presentation Overview
1. The company - Quantum Genomics
2. Reasons for and advantages of coming
to France
3. Problems
4. Advice
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Business Overview
Biotech Startup company with 1 US
Employee, 5 French
Owned by a New Jersey-based US Holding
Company, financed by US investors
 Investors wrongly “Afraid” of French
Law/Taxes
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Business Model
Public and Private Labs
Research manipulations and tests
Compounds and
knowledge
Academic Research
Compound Discovery
Quantum Genomics
Compound Development
(Phase 2A/2B)
Pharmaceutical
Companies
Compound Development
(Phase 3)
Royalties and licensing
fees
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Business Opportunity
Saturated US Market
Underexploited European Market
 Most universities still accessible
 Specific compounds still available
 Few Competitors
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Opportunity Exploitation
Conclusion: Establish business in Europe
Action: In 2006 Quantum Genomics decided to
locate its European Headquarter in MassyPalaiseau
Strategic Vision: Use French location as a
stepping-stone into the rest of European
Market
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Why France?
The 5 main reasons for coming to France:
1) Quality of & Access to Research
2) ‘Pole de Compétitivité’
3) Young Innovative Company (YIC) initiative
4) “Easy to Do Business in France”
5) Founding Executive is French
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
1) Quality of and Access to Research
Research Requires Patients/Blood/Cells
 80% of Inserm research is done in
Hospitals
 50% of researchers/labs are in Paris
Region
Academic Researchers More Open to French
Company
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
2) ‘Pole de Compétitivité’
There’s a biotech cluster in the south of Paris/ The Saclay Region
Business cluster
a geographic concentration of interconnected businesses,
suppliers, and associated institutions in a particular field
Advantages
Research suggests that clusters have the potential to affect
competition in three ways (Porter, 1990):
1) by increasing the productivity of the companies in the cluster,
2) by driving innovation in the field
3) by stimulating new businesses in the field
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
3) Young Innovative Company
Initiative
Which companies qualify?
Main Benefits:
1) Provide incentives for companies
 Social Costs
 Income Tax Benefits
2) Provide Incentives for Investors
 Capital Gains Benefits
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
4) “Easy to Do Business in France”
“Myth” of the 35 hour work week
No language barrier: researchers are used to
publishing and working in English
Invest In France Agency assists with placement
Segard believes individual life in France is quite
easy, which is good for French employees
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
5) Founding Executive is French
This was also an important reason for choosing
for France
Footnote: Bias in location decision
He might have been more aware more aware
of opportunities in France than elsewhere in
Europe
He might have a natural preference for
France
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Why Saclay region?
Excellent Researchers/Facilities
Real estate prices are higher in Paris
than in Saclay
‘Pole de Compétitivité’ in Saclay
Easy Access to Transportation
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Problems
The company did not encounter any significant
problems in its adaptation process to France
This can be explained by the fact that the
founder was French
 Knowledge of French labor laws
 Knowlegde of French fiscal system
 Used to French culture
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Advice for new entrants
Consider Incentive Programs From French Government (e.g.
YIC)
Have an External Financing Plan: Low venture capital activity in
France
Employ locals who are familiar with the French labor laws and
fiscal system
Lionel Segard (2006)
Lionel Segard, CEO
Quantum Genomics Corp SAS
L’Odyssée
2-12, chemin des Femmes
91300 Massy
[email protected]
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Bibliography
References
M.E. Porter (1990). The competitive advantage of
nations. Free Press. New York.
www.ville-palaiseau.fr
www.competitivite.gouv.fr
www.france-biotech.org
www.investinfrance.org
www.quantum-genomics.com
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Thank you for your attention!
Any Questions??
11 / 12 / 2006
Best in France Case Study
Quantum Genomics
Our Team
Eric Mara, 26 Far Hills Drive, Avon, CT
06001, USA
Amelie Bommier, 18 bis rue du plateau StAntoine, 78150 Le Chesnay, France
Richard Roberts, St. Leonards, Station Road,
Dairsie, Fife, Scotland, KY15 4SP
Willem Giebels; Middelreuvelt 24, 5971 DD
Grubbenvorst, The Netherlands.
11 / 12 / 2006
Best in France Case Study
Quantum Genomics